Recent News for IRWD - Ironwood Pharmaceuticals, Inc.

Date Title
Feb 19 Ironwood Pharmaceuticals to Present at Upcoming Investor Conferences
Feb 17 Ironwood Pharmaceuticals, Inc. 2020 Q4 - Results - Earnings Call Presentation
Feb 17 Ironwood Pharmaceuticals, Inc.'s (IRWD) CEO Mark Mallon on Q4 2020 Results - Earnings Call Transcript
Feb 17 Ironwood Pharmaceuticals Inc (IRWD) Q4 2020 Earnings Call Transcript
Feb 17 Ironwood shares rise on Linzess powered fourth-quarter beat
Feb 17 Recap: Ironwood Pharmaceuticals Q4 Earnings
Feb 17 Ironwood Pharmaceuticals EPS beats by $0.07, beats on revenue
Feb 17 Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results, Exceeding or Meeting Full Year 2020 Financial Guidance; Provides Full Year 2021 Financial Guidance
Feb 17 Earnings Scheduled For February 17, 2021
Feb 16 Ironwood Pharmaceuticals Q4 2020 Earnings Preview
Feb 14 The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week
Feb 10 Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q4 Earnings Expected to Decline
Feb 9 Ironwood Pharmaceuticals CEO exit may be catalyst for sale, analyst says
Feb 9 The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement
Feb 9 Ironwood CEO Steps Down Months After Clinical Trial Failure, Names Thomas McCourt As Interim Chief Executive
Feb 8 Ironwood Pharma's CEO Mark Mallon to step down
Feb 8 Ironwood Pharmaceuticals Announces CEO Transition
Feb 8 Investors Aren't Entirely Convinced About Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) Earnings
Feb 3 Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2020 Investor Update Call
Jan 21 The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping
Jan 5 Ironwood Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference
Dec 5 Ironwood (IRWD) Up 19.7% Since Last Earnings Report: Can It Continue?
Dec 4 JAZZ's Zepzelca Combo SCLC Study Fails, Drug Still Promising
Dec 3 Ironwood Pharmaceuticals Appoints Jay P. Shepard to Board of Directors
Nov 30 FibroGen's (FGEN) Evrenzo Approved in Japan for Another Indication
Back to the Main IRWD Page...